ScholarIQanswers from OpenAlex

The utilization and challenges of Japan's MID‐NET<sup>®</sup> medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies

PaperCitations, authors & open-access status

The utilization and challenges of Japan's MID‐NET<sup>®</sup> medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies is a paper indexed in ScholarIQ from OpenAlex.

How many citations does The utilization and challenges of Japan's MID‐NET<sup>®</sup> medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies have?

ScholarIQcitation count

The utilization and challenges of Japan's MID‐NET<sup>®</sup> medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies has 40 citations in the OpenAlex counts ScholarIQ stores.

When was The utilization and challenges of Japan's MID‐NET<sup>®</sup> medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies published?

ScholarIQyear

The utilization and challenges of Japan's MID‐NET<sup>®</sup> medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies has 2019 year in the ScholarIQ index.

What is the open-access status of The utilization and challenges of Japan's MID‐NET<sup>®</sup> medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies?

ScholarIQoa status

The utilization and challenges of Japan's MID‐NET<sup>®</sup> medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies has closed oa status in the ScholarIQ index.

What is the DOI of The utilization and challenges of Japan's MID‐NET<sup>®</sup> medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies?

ScholarIQdoi

The DOI for The utilization and challenges of Japan's MID‐NET<sup>®</sup> medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies is on the source record.

What is the PMID of The utilization and challenges of Japan's MID‐NET<sup>®</sup> medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies?

ScholarIQpmid

The PMID for The utilization and challenges of Japan's MID‐NET<sup>®</sup> medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies is on the source record.

What is the OpenAlex record for The utilization and challenges of Japan's MID‐NET<sup>®</sup> medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies?

ScholarIQopenalex

The OpenAlex for The utilization and challenges of Japan's MID‐NET<sup>®</sup> medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial